|
Brief Reports
Citations 361-370 of 1234 total displayed.
|
Past content
(since Jul 1999):
|
Dasatinib (BMS-354825) is active in Philadelphia chromosome–positive chronic myelogenous leukemia after imatinib and nilotinib (AMN107) therapy failure
- Alfonso Quintas-Cardama, Hagop Kantarjian, Dan Jones, Claude Nicaise, Susan O'Brien, Francis Giles, Moshe Talpaz, and Jorge Cortes
Blood 2007; 109: 497-499.
[Abstract]
[Full text]
[PDF]
MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutation
- Francis J. Giles, Jorge Cortes, Dan Jones, Donald Bergstrom, Hagop Kantarjian, and Steven J. Freedman
Blood 2007; 109: 500-502.
[Abstract]
[Full text]
[PDF]
Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report
- Barbara C. Engel, Greg M. Podsakoff, Joanna L. Ireland, E. Monika Smogorzewska, Denise A. Carbonaro, Kathy Wilson, Ami Shah, Neena Kapoor, Mirna Sweeney, Mark Borchert, Gay M. Crooks, Kenneth I. Weinberg, Robertson Parkman, Howard M. Rosenblatt, Shi-Qi Wu, Michael S. Hershfield, Fabio Candotti, and Donald B. Kohn
Blood 2007; 109: 503-506.
[Abstract]
[Full text]
[PDF]
Low rhodamine 123 retention identifies long-term human hematopoietic stem cells within the Lin–CD34+CD38– population
- Joby L. McKenzie, Katsuto Takenaka, Olga I. Gan, Monica Doedens, and John E. Dick
Blood 2007; 109: 543-545.
[Abstract]
[Full text]
[PDF]
VWF protects FVIII from endocytosis by dendritic cells and subsequent presentation to immune effectors
- Suryasarathi Dasgupta, Yohann Repessé, Jagadeesh Bayry, Ana-Maria Navarrete, Bharath Wootla, Sandrine Delignat, Theano Irinopoulou, Caroline Kamaté, Jean-Marie Saint-Remy, Marc Jacquemin, Peter J. Lenting, Annie Borel-Derlon, Srinivas V. Kaveri, and Sébastien Lacroix-Desmazes
Blood 2007; 109: 610-612.
[Abstract]
[Full text]
[PDF]
Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium
- Kiichiro Yano, Daniel Gale, Steffen Massberg, Pavan K. Cheruvu, Rita Monahan-Earley, Ellen S. Morgan, David Haig, Ulrich H. von Andrian, Ann M. Dvorak, and William C. Aird
Blood 2007; 109: 613-615.
[Abstract]
[Full text]
[PDF]
Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase
- Antonija Jurak Begonja, Jörg Geiger, Natalia Rukoyatkina, Steffen Rauchfuss, Stepan Gambaryan, and Ulrich Walter
Blood 2007; 109: 616-618.
[Abstract]
[Full text]
[PDF]
Increased surveillance of cells in mitosis by human NK cells suggests a novel strategy for limiting tumor growth and viral replication
- Esther N. M. Nolte–'t Hoen, Catarina R. Almeida, Nadia R. Cohen, Shlomo Nedvetzki, Helen Yarwood, and Daniel M. Davis
Blood 2007; 109: 670-673.
[Abstract]
[Full text]
[PDF]
Regulation of the Arf tumor suppressor in Eµ-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis
- David Bertwistle and Charles J. Sherr
Blood 2007; 109: 792-794.
[Abstract]
[Full text]
[PDF]
Imatinib mesylate discontinuation in patients with chronic myelogenous leukemia in complete molecular remission for more than 2 years
- Philippe Rousselot, Francoise Huguet, Delphine Rea, Laurence Legros, Jean Michel Cayuela, Odile Maarek, Odile Blanchet, Gerald Marit, Eliane Gluckman, Josy Reiffers, Martine Gardembas, and François-Xavier Mahon, The Intergroupe Français des Leucémies Myéloïdes Chronique (FI
 LMC)
Blood 2007; 109: 58-60.
[Abstract]
[Full text]
[PDF]
|
|
